|
|
| Phases of Development | Preclinical | Phase I | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Endocrine / Metabolic | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Gastrointestinal | 0 | 0 | 2 | 0 | 0 | 0 | 0 | | Genitourinary | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Inflammation | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Neurology | 5 | 1 | 6 | 4 | 4 | 2 | 13 |
|
|
Products Targeting Dopamine D2 receptor